Joel Pitz
Analyst · Wells Fargo
Thanks, Deanna. Good morning to everyone on the call. I'll walk through our financial performance for the fourth quarter and full year, provide updates on our capital position and share details of our outlook for 2026. Our full year and fourth quarter results can be found on Slides 4 and 5. We delivered strong full year results, meeting or exceeding our 2025 financial targets. Full year non-GAAP operating earnings, excluding significant variances, were $1.9 billion or $8.55 per diluted share. This represents a 12% increase in EPS over 2024 at the high end of our 9% to 12% EPS target. Results for the quarter were also strong, with non-GAAP operating earnings of $499 million or $2.24 per diluted share, a 7% increase over a very strong fourth quarter in 2024. Variable investment income improved from the third quarter with quarterly and full year returns better than 2024 and in line with the assumptions provided during our 2025 outlook call. In addition to the OE improvement, similar to last quarter, we had a gain on a real estate transaction reflected below the line of approximately $40 million pretax. Non-GAAP operating ROE for 2025 was 15.7%, an improvement of 120 basis points compared to the year-ago period and at the high end of our 14% to 16% target range. Margins also strengthened, expanding 80 basis points to 31% for full year 2025. This improvement was driven by top-line growth and disciplined expense management with compensation and other operating expenses increasing 2%. These results reflect strong business fundamentals across the enterprise, disciplined expense management while investing in the business and favorable market conditions. Turning to capital and liquidity, we ended the year in a strong position with $1.6 billion of excess and available capital. This includes $800 million at the holding company at our targeted level, $300 million in our subsidiaries and $480 million in excess of our target 375% risk-based capital ratio, which is 406% at year-end. We returned $1.5 billion to shareholders in 2025, comfortably within our target. This includes $851 million of share repurchases and $684 million of common stock dividends. In the fourth quarter alone, we returned $448 million of capital to shareholders, including $275 million in share repurchases and $172 million in dividends. Last night, we announced an $0.80 common stock dividend payable in the first quarter of 2026. This is a $0.01 increase from the dividend paid in the fourth quarter and a 7% increase over the first quarter of 2025. This aligns with our targeted 40% dividend payout ratio and demonstrates our confidence in continued growth and strong capital generation. Moving to AUM and net cash flow. Total company managed AUM was $781 billion at year-end, down $3 billion sequentially. Compared to the fourth quarter of 2024, AUM increased 10%. The modest sequential decline was primarily driven by $13 billion of disposed operations, which has no impact on our future earnings outlook. Net cash flow was negative $2 billion for the quarter with positive private flows of $1 billion. As a reminder, our net cash flow definition excludes the $2.4 billion of dividends reinvested within our mutual fund franchise. Moving to the businesses. The following commentary excludes significant variances, which can be found on Slides 17 and 18. Starting with RIS and as shown on Slide 6, we delivered strong results. Full year net revenue grew 4%, comfortably within our target range, driven by growth in the business and favorable markets. Operating margin of 41% expanded 90 basis points over 2024 and was at the top end of our target range, reflecting our disciplined focus on profitable revenue growth. Pretax operating earnings grew 6% over 2025 (sic) [ 2024 ] and 3% over the prior-year quarter, driven by higher net revenue and disciplined expense management. Fundamentals across retirement business remained strong. WSRS recurring deposits grew 5% for both the full year and from the year-ago quarter. Transfer deposits totaled $35 billion for the year, up 9%, including $3 billion in pension risk transfer sales. The fourth quarter was particularly strong with transfer deposits of $12 billion, up 35% year-over-year. Turning to Slide 7. Principal Asset Management delivered strong earnings on revenue growth and margin expansion. Within Investment Management, full year adjusted revenue growth of 4% was at the low end of our 4% to 7% target range. The divested businesses had a 150-basis-point impact on net revenue growth in 2025 with no corresponding impact to earnings. Pretax operating earnings for the year were strong, increasing 5% to $610 million, driven by growth in net revenue and margin expansion. Full year operating margin of 36% expanded 60 basis points from a year ago and is within our target range. Within International Pension, we delivered strong AUM of $154 billion, an increase of 24% year-over-year. For the full year, while we had strong fee revenue growth in Latin America, net revenue declined 2% due to foreign currency and the Hong Kong business, which we are exiting. Operating margin of 46% for the full year expanded 170 basis points from 2024 and was within our 45% to 49% target range. Fourth quarter results reflect typical seasonality and onetime expenses, and we expect improved earnings in the first quarter. Turning to Slide 8. Benefits and Protection delivered pretax operating earnings of $177 million in the quarter, up 7% compared to the prior-year quarter, driven by Life Insurance, which was up 29%. Full year pretax operating earnings increased 7%, driven by 11% growth in Specialty Benefits. Starting with Specialty Benefits, full year premium fee growth of 3% was below our target range, driven by lower net new business. Operating margin of 16% for the full year expanded 120 basis points compared to 2024 and was at the high end of our target range of 13% to 16%. The adjusted loss ratio of 59% for the year was the best in our history, improving 130 basis points from 2024 and below our 60% to 64% target range. These results were driven by favorable experience across group life and group disability. Dental underwriting results show meaningful improvement with another quarter of year-over-year gains. These strong underwriting results underscore the effectiveness of our management actions to drive profitable growth. In Life Insurance, full year premium and fees increased 3%, within our 1% to 4% target range, as strong business market growth of 15% more than offset the runoff of our legacy block. Operating margin of 10% for the year was below our 12% to 16% target range, impacted by higher claim severity during the first half of the year. Long-term mortality remains within our expectations. As we close out 2025, our results reflect strong execution across the enterprise. We delivered earnings per share growth of 12% and ROE of 16%, both at the high end of our target; expanded margins in every segment and generated strong free capital flow conversion of 92%. We maintained our disciplined approach to capital deployment, returning $1.5 billion to shareholders. This momentum, combined with our strategic focus on the retirement ecosystem, small and midsized businesses and global asset management positions us well as we enter 2026. Before turning to outlook, we want to acknowledge that consistent with past practice, supplemental investment slides have been made available on our website. Now turning to our outlook for 2026. As shown on Slides 10 and 11, we are well positioned to once again deliver on our enterprise financial targets in 2026, with 9% to 12% growth in earnings per share, 75% to 85% free capital flow conversion and 15% to 17% return on equity. The ROE target has increased, reflecting our strong 2025 results, competitive positioning and the capital efficiency of our diversified business mix. These targets assume normal market conditions throughout 2026 and reinforce our confidence in the sustained delivery of our financial targets. We remain committed to returning excess capital to shareholders and are targeting $1.5 billion to $1.8 billion of capital deployments in 2026. This includes $800 million to $1.1 billion of share repurchases and an increasing common stock dividend, aligned with our targeted dividend payout ratio. Our EPS target is on an excluding significant variances basis and therefore, assumes run rate variable investment income, or VII. In 2026, we once again expect our reported VII results to improve year-over-year. We will continue to quantify the impacts on reported results from higher or lower-than-expected VII as a significant variance in our earnings calls throughout the year. Turning to our business units. Slide 11 outlines our financial targets and 2026 outlook considerations. Notably, our strong execution and profitable growth gives us confidence to revise several of our margin targets upward. In RIS, building on the strong results in 2025, we are increasing our margin target to 38% to 41% and expect to be at the upper end of the margin range in 2026. Net revenue target of 2% to 5% remains intact. The following outlook commentary for Investment Management and International Pension accounts for our previously announced divestitures with the related impacts detailed on Slide 10. In Investment Management, we are increasing our margin target to 35% to 39%, and we remain confident in our ability to deliver on our 4% to 7% adjusted revenue growth target, consistent with 2025. In International Pension, our margin target is increasing to 46% to 50%, with 2026 expected in the upper half of that range due to growth in higher-margin businesses. We expect to be at the low end of our 4% to 7% net revenue growth target in 2026. In Specialty Benefits, we have updated our premium and fees target to 5% to 9% to better reflect our growth expectations, which remain above industry levels. In 2026, we expect higher growth at the low end of the revised range, with growth improving throughout the year. Our margin target is increasing to 14% to 17%, with 2026 expected in the upper half of the range. Our loss ratio target of 60% to 64% remains intact, with 2026 expected to be strong and at the low end of the range. In Life, we are moving a subsidiary supporting enterprise distribution to corporate. This completes the alignment of our affiliated distribution functions within the same segment. As a result, we expect 2026 overall premium and fee growth of negative 2% to negative 4%, while business-owner market continues to grow at over 10%. Our margin target of 12% to 16% remains intact, with 2026 expected at the low end of the range. Notably, the realignment of fee revenue will have no impact on Life or total company earnings. Before opening for questions, I want to remind you of a few seasonality impacts. In Investment Management, the first quarter is typically our lowest quarter for earnings due to seasonality and deferred compensation and elevated payroll taxes. We expect $30 million to $35 million in seasonal expenses in the first quarter of 2026. In Specialty Benefits, dental claims are typically higher in the first half of the year. Similar to the pattern in 2025, these factors will contribute to higher total company earnings in the second half of 2026 compared to the first half. Additionally, they drive the seasonal pattern of free capital flow, which increases throughout the year. As we look to 2026, we have positive momentum and are well positioned to deliver on our financial targets for a third consecutive year. This concludes our prepared remarks. Operator, please open the call for questions. from the year-ago quarter. Transfer deposits totaled $35 billion for the year, up 9%, including $3 billion in pension risk transfer sales. The fourth quarter was particularly strong with transfer deposits of $12 billion, up 35% year-over-year. Turning to Slide 7. Principal Asset Management delivered strong earnings on revenue growth and margin expansion. Within Investment Management, full year adjusted revenue growth of 4% was at the low end of our 4% to 7% target range. The divested businesses had a 150-basis-point impact on net revenue growth in 2025 with no corresponding impact to earnings. Pretax operating earnings for the year were strong, increasing 5% to $610 million, driven by growth in net revenue and margin expansion. Full year operating margin of 36% expanded 60 basis points from a year ago and is within our target range. Within International Pension, we delivered strong AUM of $154 billion, an increase of 24% year-over-year. For the full year, while we had strong fee revenue growth in Latin America, net revenue declined 2% due to foreign currency and the Hong Kong business, which we are exiting. Operating margin of 46% for the full year expanded 170 basis points from 2024 and was within our 45% to 49% target range. Fourth quarter results reflect typical seasonality and onetime expenses, and we expect improved earnings in the first quarter. Turning to Slide 8. Benefits and Protection delivered pretax operating earnings of $177 million in the quarter, up 7% compared to the prior-year quarter, driven by Life Insurance, which was up 29%. Full year pretax operating earnings increased 7%, driven by 11% growth in Specialty Benefits. Starting with Specialty Benefits, full year premium fee growth of 3% was below our target range, driven by lower net new business. Operating margin of 16% for the full year expanded 120 basis points compared to 2024 and was at the high end of our target range of 13% to 16%. The adjusted loss ratio of 59% for the year was the best in our history, improving 130 basis points from 2024 and below our 60% to 64% target range. These results were driven by favorable experience across group life and group disability. Dental underwriting results show meaningful improvement with another quarter of year-over-year gains. These strong underwriting results underscore the effectiveness of our management actions to drive profitable growth. In Life Insurance, full year premium and fees increased 3%, within our 1% to 4% target range, as strong business market growth of 15% more than offset the runoff of our legacy block. Operating margin of 10% for the year was below our 12% to 16% target range, impacted by higher claim severity during the first half of the year. Long-term mortality remains within our expectations. As we close out 2025, our results reflect strong execution across the enterprise. We delivered earnings per share growth of 12% and ROE of 16%, both at the high end of our target; expanded margins in every segment and generated strong free capital flow conversion of 92%. We maintained our disciplined approach to capital deployment, returning $1.5 billion to shareholders. This momentum, combined with our strategic focus on the retirement ecosystem, small and midsized businesses and global asset management positions us well as we enter 2026. Before turning to outlook, we want to acknowledge that consistent with past practice, supplemental investment slides have been made available on our website. Now turning to our outlook for 2026. As shown on Slides 10 and 11, we are well positioned to once again deliver on our enterprise financial targets in 2026, with 9% to 12% growth in earnings per share, 75% to 85% free capital flow conversion and 15% to 17% return on equity. The ROE target has increased, reflecting our strong 2025 results, competitive positioning and the capital efficiency of our diversified business mix. These targets assume normal market conditions throughout 2026 and reinforce our confidence in the sustained delivery of our financial targets. We remain committed to returning excess capital to shareholders and are targeting $1.5 billion to $1.8 billion of capital deployments in 2026. This includes $800 million to $1.1 billion of share repurchases and an increasing common stock dividend, aligned with our targeted dividend payout ratio. Our EPS target is on an excluding significant variances basis and therefore, assumes run rate variable investment income, or VII. In 2026, we once again expect our reported VII results to improve year-over-year. We will continue to quantify the impacts on reported results from higher or lower-than-expected VII as a significant variance in our earnings calls throughout the year. Turning to our business units. Slide 11 outlines our financial targets and 2026 outlook considerations. Notably, our strong execution and profitable growth gives us confidence to revise several of our margin targets upward. In RIS, building on the strong results in 2025, we are increasing our margin target to 38% to 41% and expect to be at the upper end of the margin range in 2026. Net revenue target of 2% to 5% remains intact. The following outlook commentary for Investment Management and International Pension accounts for our previously announced divestitures with the related impacts detailed on Slide 10. In Investment Management, we are increasing our margin target to 35% to 39%, and we remain confident in our ability to deliver on our 4% to 7% adjusted revenue growth target, consistent with 2025. In International Pension, our margin target is increasing to 46% to 50%, with 2026 expected in the upper half of that range due to growth in higher-margin businesses. We expect to be at the low end of our 4% to 7% net revenue growth target in 2026. In Specialty Benefits, we have updated our premium and fees target to 5% to 9% to better reflect our growth expectations, which remain above industry levels. In 2026, we expect higher growth at the low end of the revised range, with growth improving throughout the year. Our margin target is increasing to 14% to 17%, with 2026 expected in the upper half of the range. Our loss ratio target of 60% to 64% remains intact, with 2026 expected to be strong and at the low end of the range. In Life, we are moving a subsidiary supporting enterprise distribution to corporate. This completes the alignment of our affiliated distribution functions within the same segment. As a result, we expect 2026 overall premium and fee growth of negative 2% to negative 4%, while business-owner market continues to grow at over 10%. Our margin target of 12% to 16% remains intact, with 2026 expected at the low end of the range. Notably, the realignment of fee revenue will have no impact on Life or total company earnings. Before opening for questions, I want to remind you of a few seasonality impacts. In Investment Management, the first quarter is typically our lowest quarter for earnings due to seasonality and deferred compensation and elevated payroll taxes. We expect $30 million to $35 million in seasonal expenses in the first quarter of 2026. In Specialty Benefits, dental claims are typically higher in the first half of the year. Similar to the pattern in 2025, these factors will contribute to higher total company earnings in the second half of 2026 compared to the first half. Additionally, they drive the seasonal pattern of free capital flow, which increases throughout the year. As we look to 2026, we have positive momentum and are well positioned to deliver on our financial targets for a third consecutive year. This concludes our prepared remarks. Operator, please open the call for questions.